MedTrace Logo

Dexmetomidine in Children Undergoing General Anaesthesia

NCT03923075 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-08-14

No results posted yet for this study

Summary

The effects of dexmedetomidine on the onset of both the general anaesthesia induction and the neuromuscular blockade in children of school age will be investigated. Ten minutes before the induction of general anaesthesia, the first group will receive continuous infusion of dexmedetomidine (DEX group), while the second group will receive normal saline (Placebo group).

Conditions

  • Anesthesia

Interventions

DRUG

Dexmedetomidine

INFUSION BEFORE INDUCTION OF ANAESTHESIA

OTHER

0.9% saline

INFUSION BEFORE INDUCTION OF ANAESTHESIA

Sponsors & Collaborators

  • Attikon Hospital

    lead OTHER

Principal Investigators

  • Georgia K Kostopanagiotou · 2nd Department of Anaesthesiology, "Attikon" University Hospital

  • Paraskevi K Matsota · 2nd Department of Anaesthesiology, "Attikon" University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-02
Primary Completion
2024-01-20
Completion
2024-06-12

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03923075 on ClinicalTrials.gov